Press release
Gonorrhoea Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Evofem Biosciences, GlaxoSmithKline, Entasis, Alopexx, Nobelex, Summit Therapeutics, TherapyX, AchilleS Vaccines, Recce Pharma, VenatoRx
"Gonorrhoea Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Gonorrhoea Therapeutics Market.
The report provides a detailed description of the Gonorrhoea drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Gonorrhoea Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Gonorrhoea Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Gonorrhoea therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gonorrhoea treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Gonorrhoea drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Gonorrhoea treatment market.
Learn More about the Clinical and Commercial Development Activities in the Gonorrhoea Therapeutics Domain:
https://www.delveinsight.com/report-store/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Gonorrhoea Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Gonorrhoea pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Request for Sample PDF to Understand More About the Gonorrhoea Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Gonorrhoea Therapeutics Analysis
Gonorrhea can lead to serious health complications if left untreated, including pelvic inflammatory disease (PID) in women, which can result in infertility or ectopic pregnancies. It can also increase the risk of acquiring or transmitting HIV. Treatment for gonorrhea typically involves antibiotics to eliminate the bacterial infection. However, due to the increasing prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae, treatment protocols change over time.
There are approx. 12+ key companies developing therapies for Gonorrhoea. Currently, GlaxoSmithKline is leading the therapeutics market with its Gonorrhoea drug candidates in the most advanced stage of clinical development.
Gonorrhoea Companies in the Therapeutics Market Include:
• Evofem Biosciences
• GlaxoSmithKline
• Entasis Therapeutics
• Alopexx Pharmaceuticals
• Nobelex Biotech
• Summit Therapeutics
• TherapyX
• AchilleS Vaccines
• Recce Pharmaceuticals
• VenatoRx Pharmaceuticals
And many others
Emerging and Marketed Gonorrhoea Therapies Covered in the Report Include:
• Gepotidacin: GlaxoSmithKline
• Zoliflodacin: Entasis Therapeutics
• SMT-571: Summit Therapeutics
• F 598: Alopexx Pharmaceuticals
• EVO100: Evofem Biosciences
• ETX-0914: Entasis Therapeutics
And many more
Get an in-depth Assessment of the Emerging Therapies and Gonorrhoea Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Gonorrhoea Current Treatment Patterns
4. Gonorrhoea - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Gonorrhoea Late-Stage Products (Phase-III)
7. Gonorrhoea Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Gonorrhoea Discontinued Products
13. Gonorrhoea Product Profiles
14. Gonorrhoea Companies
15. Gonorrhoea Drugs
16. Dormant and Discontinued Products
17. Gonorrhoea Unmet Needs
18. Gonorrhoea Future Perspectives
19. Gonorrhoea Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Healthcare Consulting and Competitive Intelligence Services by DelveInsight
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Functional Electrical Stimulation (FES) Devices Market
https://www.delveinsight.com/report-store/functional-electrical-stimulation-fes-devices-market
Hypoactive Sexual Desire Disorder Market
https://www.delveinsight.com/report-store/hypoactive-sexual-desire-disorder-hsdd-market
Complicated Intra-Abdominal Infections Market
https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market
Malignant Pleural Mesothelioma (MPM) Market
https://www.delveinsight.com/report-store/malignant-pleural-mesothelioma-market
Mitochondrial Myopathies Market
https://www.delveinsight.com/report-store/mitochondrial-myopathies-market
Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market
Mayus Kinase (jak) Inhibitors Market
https://www.delveinsight.com/report-store/mayus-kinase-inhibitors-market
Acute Heart Failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bacterial Vaginosis Market
https://www.delveinsight.com/report-store/bacterial-vaginosis-market
Hyperphosphatemia Market
https://www.delveinsight.com/report-store/hyperphosphatemia-market
Pleural Effusion Market
https://www.delveinsight.com/report-store/pleural-effusion-market
Epidermolysis Bullosa Market
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market
Gestational Diabetes Market
https://www.delveinsight.com/report-store/gestational-diabetes-market
Intratumoral Cancer Therapies Market
https://www.delveinsight.com/report-store/intratumoral-cancer-therapies-market
Wasting Syndrome Market
https://www.delveinsight.com/report-store/wasting-syndrome-market
Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market
Vagus Nerve Stimulator (VNS) Global Market
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market
Abetalipoproteinemia Market
https://www.delveinsight.com/report-store/abetalipoproteinemia-market
Myelofibrosis (MF) Market
https://www.delveinsight.com/report-store/myelofibrosis-mf-market
Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Homozygous Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market
Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market
West Nile Encephalitis Market
https://www.delveinsight.com/report-store/west-nile-encephalitis-market
Gonorrhea Market
https://www.delveinsight.com/report-store/gonorrhea-market
Polymyositis Market
https://www.delveinsight.com/report-store/polymyositis-market
Subarachnoid Hemorrhage Market
https://www.delveinsight.com/report-store/subarachnoid-hemorrhage-market
Acute Pancreatitis Market
https://www.delveinsight.com/report-store/acute-pancreatitis-market
Acute Respiratory Distress Syndrome (ARDS) Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market
Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
PARP Inhibitors Market
https://www.delveinsight.com/report-store/parp-inhibitors-competitive-landscape-pipeline-and-market-analysis
Bacterial Conjunctivitis Market
https://www.delveinsight.com/report-store/bacterial-conjunctivitis-market
Desmoplastic Small Round Cell Tumors (DSRCTS) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market
Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market
Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
PCSK9 Inhibitors Market
https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market
Dravet Syndrome Market
https://www.delveinsight.com/report-store/dravet-syndrome-market
Genital Warts Market
https://www.delveinsight.com/report-store/genital-warts-condyloma-acuminatum-market
Orthopedic Trauma Devices Market
https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market
Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market
Erythema Market
https://www.delveinsight.com/report-store/erythema-market
Primary Open Angle Glaucoma (POAG) Market
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market
Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market
Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market
https://www.delveinsight.com/report-store/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market
Traumatic Brain Injury Assessment Devices Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-assessment-management-devices-market
Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market
Hormone Sensitive Advanced Prostate Cancer Market
https://www.delveinsight.com/report-store/hormone-sensitive-advanced-prostate-cancer-market
Neuromodulation Devices Global Market
https://www.delveinsight.com/report-store/neuromodulation-devices-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gonorrhoea Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Evofem Biosciences, GlaxoSmithKline, Entasis, Alopexx, Nobelex, Summit Therapeutics, TherapyX, AchilleS Vaccines, Recce Pharma, VenatoRx here
News-ID: 3185076 • Views: …
More Releases from DelveInsight Business Research LLP
Presbyopia Market Size (7MM) was ~USD 17,000 Million in 2023 and it is expected …
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of presbyopia, historical and forecasted epidemiology as well as the presbyopia market trends in the United States, EU4, and the UK (Germany, France, Italy, Spain) and the United Kingdom, and Japan.
Discover Key Insights into the Presbyopia Market with DelveInsight's In-Depth Report @ Presbyopia Market Size- https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Presbyopia Market Report
• In…
Peripheral Neuropathic Pain Market Size (7MM) was ~USD 12,000 Million in 2023, w …
DelveInsight's "Peripheral Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Peripheral Neuropathic Pain, historical and forecasted epidemiology as well as the Peripheral Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To know in detail about the Peripheral Neuropathic Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Peripheral Neuropathic Pain Market…
PD-L1 inhibitors Market Size (7MM) was ~USD 36 Billion in 2023 and it is expecte …
DelveInsight's "PD-L1 Inhibitors Market Report" provides an in-depth analysis of the current and future market landscape for PD-L1 inhibitors across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and other key geographies. The report offers comprehensive epidemiological insights, treatment algorithms, evolving biomarker trends, and the competitive environment surrounding PD-L1-targeting therapies. This report serves as a vital resource for pharmaceutical companies, investors, clinical researchers, and oncologists…
Advanced Renal Cell Carcinoma Treatment Market (7MM) is expected to grow at a de …
DelveInsight's "Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as well as the Antibody Drug Conjugates market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Advanced Renal Cell Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Advanced…
More Releases for Gonorrhoea
Gonorrhea Clinical Trial Pipeline Appears Robust With 12+ Key Pharma Companies A …
DelveInsight's "Gonorrhea Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Gonorrhea pipeline landscape. It covers the Gonorrhea pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gonorrhea therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Gonorrhea pipeline products in this space.
Download DelveInsight's comprehensive Gonorrhea Pipeline Report to explore emerging therapies,…
Gonorrhoea Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Tri …
DelveInsight's "Gonorrhoea Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Gonorrhoea pipeline landscape. It covers the Gonorrhoea pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gonorrhoea pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Gonorrhoea pipeline products in this space.
Explore our latest breakthroughs in Gonorrhoea Research. Learn…
CT/NG Testing Market Projected to Grow at 8.1% CAGR, Surpassing USD 3.2 Billion …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CT/NG Testing Market- (By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User (Diagnostics & Laboratories, Hospitals & Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global CT/NG Testing Market is valued at US$…
Gonorrhea Treatment Market Size, Share, Report and Forecast 2024-2032
Gonorrhea Treatment Market Outlook
The gonorrhea treatment market was estimated to be worth USD 1.48 billion in 2023. The market is likely to grow at a rate of 4.7% in the forecasted period 2024-2032. Within this growth rate, the market value is estimated to reach about USD 2.24 billion by 2032. The market is primarily driven by the increased prevalence of sexually transmitted infections and the expected launch of novel therapies.
Gonorrhea…
Gonorrhea Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Gonorrhea therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Gonorrhea Pipeline Insight, 2023" report by DelveInsight…
Gonorrhoea Market Size was approximately USD XX Million in 2022, estimates Delve …
"The Gonorrhoea Market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Gonorrhoea pipeline products will significantly revolutionize the Gonorrhoea market dynamics"
The Gonorrhoea market report provides current treatment practices, Gonorrhoea emerging drugs, market share of individual therapies, and current and forecasted 7MM a Gonorrhoea market size from 2019 to 2032. The report also covers current Gonorrhoea treatment…
